임상시험

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

NCT: NCT04396808 · ACTIVE_NOT_RECRUITING

NCT IDNCT04396808

상태ACTIVE_NOT_RECRUITING

시작일2020-11-05

SponsorUniversity of Michigan Rogel Cancer Center (OTHER)

First posted2020-05-21

Last updated2026-09-09

간략 요약

This study seeks to determine the clinical impact of Gene Expression Classifier (GEC) testing in prostate cancer care while also developing a pragmatic approach for improved GEC clinical use and future study.

공식 출처

ClinicalTrials.gov에서 보기 →

데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.